Biosimilar substitution in France: no way back?
Beginning on 1 January 2014, French pharmacists are now legally permitted to substitute a biosimilar for the prescribed (reference) biological medicine as long as the prescribing physician has not marked the prescription as ‘non-substitutable’. According to the new law, substitution is allowed only when initiating a course of treatment and if the biosimilar belongs to […]